Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001718903-19-000002
Filing Date
2019-04-10
Accepted
2019-04-10 11:28:10
Documents
69
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F form20-f.htm 20-F 1305883
2 EXHIBIT 2.2 exhibit22.htm EX-2.2 443510
3 EXHIBIT 12.1 exhibit121.htm EX-12.1 17665
4 EXHIBIT 12.2 exhibit122.htm EX-12.2 20041
5 EXHIBIT 13.1 exhibit131.htm EX-13.1 7934
6 EXHIBIT 13.2 exhibit132.htm EX-13.2 7468
7 EXHIBIT 21.1 exhibit211.htm EX-21.1 3817
8 EXHIBIT 23.1 exhibit231.htm EX-23.1 2549
  Complete submission text file 0001718903-19-000002.txt   5590406

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT rlm-20181231.xml EX-101.INS 899760
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlm-20181231.xsd EX-101.SCH 31936
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlm-20181231_cal.xml EX-101.CAL 72709
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlm-20181231_def.xml EX-101.DEF 154543
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlm-20181231_lab.xml EX-101.LAB 511394
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlm-20181231_pre.xml EX-101.PRE 300430
Mailing Address CANNON PLACE 78 CANNON STREET LONDON X0 EC4N 6AF
Business Address CANNON PLACE 78 CANNON STREET LONDON X0 EC4N 6AF 484-321-2700
Realm Therapeutics plc (Filer) CIK: 0001718903 (see all company filings)

EIN.: 133933588 | State of Incorp.: X0
Type: 20-F | Act: 34 | File No.: 001-38522 | Film No.: 19740991
SIC: 2834 Pharmaceutical Preparations